Table 3.
Association of Total Agatston Score for Vascular Calcification and Clinical Variables
| Variable | Univariable | Multivariable | ||
|---|---|---|---|---|
| Estimate (SE) | P Value | Estimate (SE) | P Value | |
|
Age (per year) |
0.06 (1.06) | 0.01 | 0.14 (1.15) | <0.01 |
|
Type of Vasculitis (TAK vs GCA) |
−0.96 (0.38) | 0.30 | 4.02 (55.70) | 0.03 |
|
Prednisone dose (per 1mg/day) |
0.05 (1.16) | 0.08 | 0.05 (1.05) | 0.04 |
|
Anti-hypertensive Medication (Yes vs No) |
2.43 (11.35) | <0.01 | 1.16 (3.19) | 0.19 |
|
Gender (Female vs Male) |
0.85 (2.3) | 0.04 | 0.12 (1.12) | 0.90 |
|
C-reactive Protein (per 1mg/L) |
−0.03 (0.97) | 0.11 | Not included in multivariable model. | |
|
Statin Medication (Yes vs No) |
1.49 (4.43) | 0.17 | ||
|
FDG-PET interpretation (Active vs Inactive) |
0.99 (2.69) | 0.29 | ||
|
Treatment duration (per year) |
0(1) | 0.53 | ||
|
Clinical Assessment (Active vs remission) |
0.44(1.55) | 0.65 | ||
|
Disease duration (per year) |
0 (1) | 0.74 | ||
|
Body mass index (per Kg/m2) |
0.02 (1.02) | 0.77 | ||
|
Erythrocyte sedimentation rate (per 1 mm/hr) |
0.003 (1.0) | 0.89 | ||
SE = standard error; TAK = Takayasu’s arteritis; GCA = giant cell arteritis, FDG-PET = 18F-fluorodeoxyglucose positron emission tomography.